Weight Loss

Can Metformin Help You Lose Weight? What the Research Says

Metformin is one of the oldest and most widely prescribed medications in the world. It has been used for type 2 diabetes management for over 60 years and has an extensive safety record. In the United States alone, tens of millions of prescriptions are written for metformin every year.

The medication works in several ways. It reduces the amount of glucose your liver produces, improves your body's sensitivity to insulin (so your cells can use glucose more effectively), and slows the absorption of sugar from food in your intestines. For patients with type 2 diabetes or prediabetes, these effects help keep blood sugar levels within a healthier range.

Metformin is taken as a pill (not an injection), usually once or twice daily. It is available as a generic medication, which makes it one of the least expensive options for patients exploring medication-assisted weight management. A month's supply often costs under $10 with most insurance plans.

Unlike GLP-1 medications such as Ozempic and Wegovy, metformin does not require prior authorization from insurance. Because it is a well-established generic medication with a clear clinical indication, most insurance plans cover it without additional paperwork. This simplicity is a real advantage for patients who find the insurance process frustrating or want to start treatment quickly.

Metformin comes in two formulations: immediate-release and extended-release (ER). The extended-release version is taken once daily and tends to cause fewer stomach-related side effects, which is why Dr. Gougian typically starts patients on the ER formulation. Both versions are inexpensive and widely available at any pharmacy.

Metformin is not FDA-approved specifically for weight loss. However, weight reduction is a well-documented effect, and physicians (including Dr. Gougian) sometimes prescribe it off-label as part of a comprehensive weight management plan when the clinical situation supports it.

The Diabetes Prevention Program (DPP), one of the largest clinical trials ever conducted on metformin, showed that participants taking metformin lost an average of about 5 to 7 pounds over the study period. More importantly, many maintained that loss over the long term, something that is notably difficult with weight loss interventions. The weight loss with metformin tends to be modest compared to newer GLP-1 medications, but it is consistent and sustainable for many patients.

A key distinction: metformin does not suppress appetite the way GLP-1 medications do. Its weight loss effects appear to come from improved insulin sensitivity, changes in how your body processes and stores energy, and, for some patients, a mild reduction in appetite. Patients who have insulin resistance or metabolic syndrome tend to see more pronounced results.

Long-term data is also encouraging. Several follow-up studies from the DPP showed that participants who continued taking metformin maintained their weight loss over 10 to 15 years. While the absolute number of pounds lost is more modest than what GLP-1 medications produce, the durability of metformin's effect is noteworthy. Weight regain is one of the central challenges in obesity treatment, and metformin performs well on that measure.

Metformin has also shown benefits beyond blood sugar and weight. Research suggests it may reduce the risk of certain cancers, improve cardiovascular outcomes, and potentially have anti-aging effects, though those areas are still being studied. For a medication that costs a few dollars a month, the risk-benefit profile is remarkably favorable for the right patient.

Not every patient who wants to lose weight is a good fit for metformin. Dr. Gougian typically considers metformin for weight management when one or more of the following applies.

You have insulin resistance or prediabetes. This is where metformin shines. If your labs show a high fasting glucose, high insulin levels, or a hemoglobin A1C in the prediabetes range, metformin addresses the underlying metabolic dysfunction, not just the number on the scale. Weight loss in this scenario is often a downstream benefit of improved metabolic health.

You are looking for a low-cost, low-risk starting point. For patients who are not yet ready for injectable medications or who want to try a conservative approach first, metformin offers a reasonable entry point. It has been used for decades, the side effect profile is well understood, and the financial barrier is minimal.

You are taking a GLP-1 medication and need additional support. Metformin is sometimes used alongside GLP-1 medications like Wegovy or Mounjaro. The two work through different mechanisms and can complement each other, particularly in patients with concurrent type 2 diabetes or significant insulin resistance.

You have polycystic ovary syndrome (PCOS). Metformin has been used for decades in patients with PCOS, where insulin resistance plays a central role. For patients with PCOS who are also trying to manage their weight, metformin addresses one of the underlying hormonal drivers and can make weight loss more achievable alongside dietary changes.

You cannot tolerate the side effects of GLP-1 medications. Some patients experience persistent nausea, vomiting, or other gastrointestinal symptoms on GLP-1 medications that do not resolve with dose adjustments. For these patients, metformin offers a different mechanism with a different side effect profile that may be easier to live with.

Patients with certain kidney conditions, liver disease, or a history of lactic acidosis may not be good candidates for metformin. This is why a physician-guided approach matters. Lab work and medical history inform the decision, not a checklist on a website.

Patients often ask how metformin compares to medications like Ozempic, Wegovy, Mounjaro, and Zepbound. Here is a straightforward comparison.

Weight loss magnitude. GLP-1 medications typically produce more significant weight loss. Clinical trials show average losses of 15 to 21% of body weight with GLP-1 medications compared to roughly 2 to 5% with metformin. If substantial weight loss is the primary goal, GLP-1 medications are generally more effective.

Cost. This is where metformin has a clear advantage. Generic metformin costs a few dollars per month. GLP-1 medications can cost over $1,000 per month without insurance, and even with coverage, copays can be significant. For patients without insurance coverage for GLP-1 medications, metformin may be the more realistic long-term option.

Administration. Metformin is a pill taken daily. GLP-1 medications are weekly injections. Some patients strongly prefer one approach over the other, and that preference matters for long-term adherence.

Side effects. Both classes of medication can cause gastrointestinal side effects, but the profiles differ. Metformin commonly causes digestive discomfort, particularly when starting (more on this below). GLP-1 medications commonly cause nausea during dose escalation. For most patients on either medication, side effects improve over time.

Combination therapy. For some patients, the best approach is using both. Metformin addresses insulin resistance at its root while a GLP-1 medication provides stronger appetite reduction and greater weight loss. Dr. Gougian evaluates whether combination therapy makes sense based on your labs, your response to each medication individually, and your overall health goals. Not everyone needs both, but the option exists when the clinical picture supports it.

Long-term outlook. Metformin is typically taken indefinitely, similar to GLP-1 medications. Stopping either class of medication often results in gradual weight regain, though the degree varies by patient. The advantage of metformin in this context is that its low cost and well-established safety profile make long-term use more practical for many patients.

The most common side effects of metformin are gastrointestinal: stomach discomfort, bloating, gas, diarrhea, and sometimes nausea. These effects are most noticeable when you first start the medication or when your dose is increased.

For most patients, these side effects improve significantly within the first two to four weeks as your body adjusts. Starting at a lower dose and gradually increasing over several weeks is the standard approach and reduces the likelihood of significant discomfort.

The extended-release (ER) formulation of metformin tends to cause fewer gastrointestinal side effects than the immediate-release version. If you experience persistent stomach issues on immediate-release metformin, switching to the ER formulation often resolves them. Dr. Gougian typically starts patients on the ER version for this reason.

Taking metformin with food also helps. An empty stomach makes side effects worse for most people.

A less common but important side effect is vitamin B12 deficiency with long-term use. Metformin can reduce B12 absorption over time, so Dr. Gougian monitors B12 levels periodically in patients taking the medication long-term. If levels drop, supplementation is straightforward.

Lactic acidosis is a serious but quite rare side effect that sometimes gets outsized attention in patient forums and online discussions. It is most likely to occur in patients with significant kidney disease, which is why kidney function is checked before starting metformin and monitored periodically. For patients with normal kidney function, the risk is low. Decades of clinical data support this.

If side effects are a concern for you, this is something to discuss at your first visit. Dr. Gougian can walk you through what to expect based on the specific formulation and dosing she recommends, and she can adjust the plan if your body responds differently than anticipated. The goal is always to find a regimen you can stay on comfortably for the long term.

Metformin is a prescription medication, and whether it makes sense for you depends on your individual health picture. At Pandora Family Medicine, Dr. Gougian takes the time to review your labs, your metabolic health markers, and your weight loss history before recommending any medication.

Your initial weight loss visit costs $200, and follow-up visits are $150. There is no subscription, no mandatory program, and no platform fee. You see Dr. Gougian directly at every visit. She is a Diplomate of the American Board of Obesity Medicine and approaches weight management as a core part of her practice.

Whether metformin, a GLP-1 medication, or a different approach makes the most sense for you is a conversation worth having in person. The right medication depends on your labs and your goals, not on what worked for someone else.

Related Articles